We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial.
- Authors
Cuzick, Jack; Forbes, John F; Sestak, Ivana; Cawthorn, Simon; Hamed, Hisham; Holli, Kaija; Howell, Anthony; International Breast Cancer Intervention Study I Investigators
- Abstract
Initial results from the first International Breast Cancer Intervention Study (IBIS-I) found that tamoxifen reduced the risk of invasive estrogen receptor (ER)-positive tumors by 31% in women at increased risk for breast cancer, but most of the follow-up at this time was during the active treatment phase. We report an updated analysis of IBIS-I that focuses on the period after active treatment was completed, a time for which little evidence from other trials is available.
- Publication
Journal of the National Cancer Institute, 2007, Vol 99, Issue 4, p272
- ISSN
1460-2105
- Publication type
Journal Article
- DOI
10.1093/jnci/djk049